(Q48405655)

11 February 2018

title

Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. (English)

1 reference

11 February 2018

author name string

Lankas GR

1

1 reference

11 February 2018

Wise LD

2

1 reference

11 February 2018

Cartwright ME

3

1 reference

11 February 2018

Pippert T

4

1 reference

11 February 2018

Umbenhauer DR

5

1 reference

11 February 2018

publication date

1 July 1998

1 reference

11 February 2018

published in

Reproductive Toxicology

1 reference

11 February 2018

volume

12

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

457-463

1 reference

11 February 2018

Expression of a multidrug resistance gene in human cancers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Structure and expression of the human MDR (P-glycoprotein) gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

What have we learnt thus far from mice with disrupted P-glycoprotein genes?

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Function of P-glycoprotein expressed in placenta and mole

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

P-glycoproteins encoded by mdr 1b in murine gravid uterus and multidrug resistant tumor cell lines are differentially glycosylated

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900027-6

7 January 2021

10.1016/S0890-6238(98)00027-6

Identifiers

DOI

1 reference

11 February 2018

release_gzwtnrr73fcd7ftd2ej4ncxhmi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gzwtnrr73fcd7ftd2ej4ncxhmi

24 November 2022

mapped directly with Wikidata item

1 reference

11 February 2018